Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Population Pharmacokinetic Study of the Effect of Polymorphisms in the ABCB1 and CES1 Genes on the Pharmacokinetics of Dabigatran

NCT06387407 is registered in ClinicalTrials.gov with The Affiliated Hospital Of Guizhou Medical University as lead sponsor.

NCT NCT06387407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06387407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Population Pharmacokinetic Study of the Effect of Polymorphisms in the ABCB1 and CES1 Genes on the Pharmacokinetics of Dabigatran
Lead sponsor
The Affiliated Hospital Of Guizhou Medical University
Phase
Observational
Overall status
Unknown status
Start date
May 1, 2024
Completion date
November 25, 2025
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

combined analysis of polymorphisms and dabigatran pharmacokinetic parameters